Veterinary and Comparative Oncology

Papers
(The TQCC of Veterinary and Comparative Oncology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy‐treated diffuse large B‐cell lymphoma18
Issue Information18
Issue Information18
Effects of a high‐protein, increased‐fibre, dry diet supplemented with omega‐3 fatty acids on quality of life in dogs undergoing chemotherapy17
High lysyl oxidase expression is an indicator of poor prognosis in dogs with cutaneous mast cell tumours16
Investigation of efficacy of two different chemotherapy protocols used in neoadjuvant chemotherapy in clinical stages II–IV canine malignant mammary tumours14
Treatment of feline intermediate to high‐grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017–2021)14
Timely adjuvant chemotherapy improves outcome in dogs with non‐metastatic splenic hemangiosarcoma undergoing splenectomy13
Ultrasound‐guided core needle biopsy in dogs with thyroid carcinoma13
Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy13
Plasma cell‐free DNA in canine lymphoma patients as a novel material for genotyping12
Dose and Duration of Upfront Steroid Administration Have no Prognostic Impact in Dogs With Multicentric Diffuse Large B‐Cell Lymphoma12
Pre‐operative neoadjuvant vinblastine‐prednisolone in canine mast cell tumours: A single‐centre retrospective cohort study12
Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain12
Polarisation Sensitive Optical Coherence Tomography Image Characteristics for Gastrointestinal Tumours and Normal Tissues at Surgical Margins in Dogs12
Prognostic Significance of Tumour Infiltrating Lymphocytes in Canine Oral Malignant Melanoma Treated With Anti‐Programmed Cell Death Ligand 1 ( PD ‐ 11
Descriptive analysis of haemangiosarcoma occurrence in dogs enrolled in the Golden Retriever lifetime study11
Cross‐Species Transcriptomic and Network Analysis of Human and Canine Diffuse Large B‐Cell Lymphoma Identifies a Conserved Replication– DNA Damage Mo11
10
Issue Information10
Efficacy and toxicity of carboplatin in the treatment of macroscopic mesenchymal neoplasia in dogs10
Issue Information10
Immunophenotyping and Mutation Analysis of Canine Intestinal T‐Cell Lymphoma: A Comparative Pathological Study of Human Enteropathy‐Associated T‐Cell Lymphoma10
Author Index10
Issue Information10
Prognostic Value of a Histopathological Scoring System and the Ki67 Proliferation Index in Dogs With Phaeochromocytoma10
Chronic adrenergic stress and generation of myeloid‐derived suppressor cells: Implications for cancer immunotherapy in dogs10
Issue Information9
9
Use of Cystourethroscopy to Define the Gross Tumour Volume in Radiation Treatment Planning for Canine Genitourinary Carcinomas9
Effects of Lipophilic Statins on Cell Viability and Tissue Factor Expression in Canine Haemangiosarcoma Cells9
Fractionated oral dosing and its effect on cyclophosphamide pharmacokinetics in dogs with high‐grade multicentric lymphoma8
8
8
Classification and Prognostication of B‐Cell and T‐Cell Multicentric Lymphoma in Dogs Using Serum MicroRNAs8
Frontal sinus carcinoma in forty‐one dogs (2001–2022)8
Epidemiology of canine cutaneous round cell tumours on the canary archipelago in Spain7
7
Issue Information7
Author Index7
Spotlight on capecitabine for the treatment of unresectable or metastatic carcinoma of various origin: A retrospective study of 25 dogs7
7
Serum Lactate Dehydrogenase as a Potential Prognostic Biomarker in Dogs With Appendicular Osteosarcoma6
Retrospective analysis of outcome and prognostic factors of subcutaneous mast cell tumours in dogs undergoing surgery with or without adjuvant treatment6
Phase 1 Dose Escalation of Single‐Agent Mechlorethamine in Dogs With Lymphoma6
Configuration of pathologic fractures in dogs with osteosarcoma following stereotactic body radiation therapy: A retrospective analysis6
Comparison of the anticancer effects of various statins on canine oral melanoma cells6
Use of Lomustine and Prednisolone as First‐Line Treatment in Canine Multicentric Lymphoma6
Critical Questions in Genomic Diagnostics for Veterinary Oncology: What We Need to Know6
Overactivation of Signal Transducer and Activator of Transcription 3 in Canine Hepatocellular Carcinoma and Its Prognostic Significance6
Defining the relevance of surgical margins. Part two: Strategies to improve prediction of recurrence risk6
DNA Methylation and Its Effects on TRIM29 Gene Expression in the Eq6
Blood Neutrophil‐to‐Lymphocyte Ratio as a Potential Prognostic Marker in Dogs ≤10 kg With Multicentric Lymphoma6
Evaluation of the health‐related quality of life in dogs following intracranial meningioma resection using a specifically developed questionnaire6
Favourable Prognostic Significance of HER2 Mutations in Canine Pulmonary Adenocarcinoma Following 6
Quantification of circulating tumour cells over time in dogs with appendicular osteosarcoma6
Clinical Response to Imatinib Mesylate and Toxicity Profile in 35 Dogs With Mast Cell Tumours5
Molecular Classification Based on the Gene Expression Profiles in Canine Histiocytic Sarcoma Cells5
Impact of 10% Dose Reductions and Duration of Treatment Delays in the Management of Chemotherapy‐Induced Neutropenia in Dogs Treated With Common Chemotherapy Protocols: A Single‐Centre Experience5
A Multi‐Institutional Retrospective Study of 21 Dogs Having Undergone Hypofractionated Radiotherapy for Adrenal Tumours (2017–2024)5
CT ‐Based Radiomic Features Predict Cervical Lymph Node Metastasis in Dogs With Oral Malignancy: A Machine Learning Study Using Leave‐One‐Patient‐Out Cross‐Validation5
5
Stereotactic body radiation therapy as an alternative to adrenalectomy for the treatment of pheochromocytomas in 8 dogs5
Isolation of Tumour‐Derived Extracellular Vesicles From the Plasma of Dogs Affected by Intracranial Tumours Showing Heterologous and Cross‐Species Tropism: A Pilot Study5
Sodium iodide symporter immunolabelling as a predictor of clinical iodide uptake in canine thyroid carcinoma: A preliminary study5
5
Description and efficacy of a response‐based “QUAD” cyclical hypofractionated palliative‐intent radiation protocol in dogs with macroscopic solid tumours: 108 cases5
Evaluating VEGFR2 as a Target for Anti‐Tumour Therapy in Canine Melanoma5
Rescue Protocols for Canine Non‐Indolent B Cell Lymphoma: A Systematic Review5
The animal's microbiome and cancer: A translational perspective4
Correction to “ DNA Methylation and Its Effects on TRIM29 Gene Expression in the Equine Sarcoid Ti4
Comparative Response of Canine and Human Osteosarcoma Tumour Cell Lines to Molecularly Targeted Anticancer Agents at Clinically Relevant Exposures With Analysis of Genomic Biomarkers4
Vinorelbine as a Rescue Treatment for Canine Histiocytic Sarcoma: A Multicentre Retrospective Study of 18 Dogs4
Evaluating the relevance of surgical margins. Part one: The problems with current methodology4
Mass spectrometric‐based assessment of the serum kappa to lambda immunoglobulin light chain ratio (κ:λ) in dogs with immunoglobulin secretory diseases4
Newcastle disease virus LaSota strain induces apoptosis and activates the TNFα/NF‐κB pathway in canine mammary carcinoma cells4
Safety and Feasibility of Infusing Ex Vivo Expanded Allogeneic Canine Natural Killer Cells for the Treatment of Metastatic Solid Tumours4
Proteasome Inhibitor–Induced Cytotoxic Mechanisms in Canine Pulmonary Adenocarcinoma Cell Lines4
Immunological Pre‐Metastatic Niche in Dogs With Naturally Occurring Osteosarcoma4
Half‐Body Radiation Therapy Results in a Prolonged Progression‐Free Interval in Canine High‐Grade Lymphoma After First Remission4
Evaluation of serum interleukin 2 receptor and beta‐2‐microglobulin as prognostic factors for canine lymphoma: A pilot study4
Machine Learning‐Based Risk Prediction for Feline Mammary Tumours: A Comprehensive Epidemiological Analysis Using Multi‐Model Ensemble Approach4
Clinical outcomes in cats with renal carcinoma undergoing nephrectomy: A retrospective study4
Prognostic significance of CD25 expression in dogs with a noninvasive diagnosis of B‐cell lymphoma treated with CHOP chemotherapy4
Comprehensive Analysis of the Tumour Immune Microenvironment in Canine Urothelial Carcinoma Reveals Immunosuppressive Mechanisms Induced by the COX –4
Correlation between computed tomography and histological evaluation of nodal metastasis in dogs with mast cell tumours4
Sentinel lymph node mapping in canine mast cell tumours using a preoperative radiographic indirect lymphography: Technique description and results in 138 cases4
Cyclical 10‐day dosing of melphalan for canine multiple myeloma4
VCS abstract4
Issue Information4
Sentinel lymph node mapping with computed tomography lymphography for mast cell tumours and a comparison between regional and sentinel lymph node histological status: Sixty‐two cases4
0.9822518825531